Evidence map›Paper›PMID 31829530›Full record

ArticleCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology2019

Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.

Mikhail A Kolpakov, Kunal Sikder, Amrita Sarkar, Shaswati Chaki, Sanket K Shukla, Xinji Guo, Zhao Qi, Carlos Barbery, Abdelkarim Sabri, Khadija Rafiq

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Genetics of Cardiac Aging Implicate Organ-Specific Variation.medRxiv : the preprint server for health sciences · 2024
    Article
  2. Article
  3. Article
  4. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Mikhail A KolpakovCardiovascular Research Center and Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.
Kunal SikderCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Amrita SarkarDepartment of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Shaswati ChakiCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Sanket K ShuklaCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Xinji GuoCardiovascular Research Center and Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.
Zhao QiCardiovascular Research Center and Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.
Carlos BarberyCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
Abdelkarim SabriCardiovascular Research Center and Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.
Khadija RafiqCenter for Translational Medicine, Thomas Jefferson University, Philadelphia, PA, USA, khadija.rafiq@jefferson.edu.
Temple University · USThomas Jefferson University · USChildren's Hospital of Philadelphia · US

Funding

Targeting Cbl for Cardiac Repair Post-Myocardial InfarctionR01HL145177 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI SABRI, ABDELKARIM · 2019 to 2022
$2.0M
Inflammatory Proteases and Diabetic CardiomyopathyR01HL111278 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI RAFIQ, KHADIJA · 2013 to 2017
$1.9M
Protein activated Receptor-4 in Cardiac Rupture after Myocardial InfarctionR01HL139889 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI SABRI, ABDELKARIM · 2018 to 2021
$1.9M
Inflammatory serine proteases and cardiac repair post myocardial infarctionR01HL128446 · NHLBI · TEMPLE UNIV OF THE COMMONWEALTH · PI SABRI, ABDELKARIM · 2015 to 2018
$1.6M
Vevo 2100 ultrasound scannerS10OD010408 · OD · THOMAS JEFFERSON UNIVERSITY · PI FORSBERG, FLEMMING · 2012 to 2012
$525k
National Institutes of Health (NIH) RO1HL111278NHLBI NIH HHS R01 HL111278NHLBI NIH HHS R01 HL128446NHLBI NIH HHS R01 HL139889NHLBI NIH HHS R01 HL145177NIH HHS S10 OD010408
6 · The paper itself

Abstract

BACKGROUND/

aimsDiabetic cardiomyopathy (DCM) is characterized by structural and functional alterations that can lead to heart failure. Several mechanisms are known to be involved in the pathogenesis of DCM, however, the molecular mechanism that links inflammation to DCM is incompletely understood. To learn about this mechanism, we investigated the role of inflammatory serine proteases (ISPs) during the development of DCM.

methodsEight weeks old mice with deletion of dipeptidyl peptidase I (DPPI), an enzyme involved in the maturation of major ISPs, and wild type (WT) mice controls were injected with streptozotocin (50 mg/kg for 5 days intraperitoneally) and studied after 4, 8, 16, and 20 week after induction of type 1 diabetes mellitus (T1DM). Induction of diabetes was followed by echocardiographic measurements, glycemic and hemoglobulin A1c profiling, immunoblot, qPCR, enzyme activity assays, and immunohistochemistry (IHC) analysis of DPPI, ISPs, and inflammatory markers. Fibrosis was determined from left ventricular heart by Serius Red staining and qPCR. Apoptosis was determined by TUNEL assay and immunoblot analysis.

resultsIn the diabetic WT mice, DPPI expression increased along with ISP activation, and DPPI accumulated abundantly in the left ventricle mainly from infiltrating neutrophils. In diabetic DPPI-knockout (DPPI-KO) mice, significantly decreased activation of ISPs, myocyte apoptosis, fibrosis, and cardiac function was improved compared to diabetic WT mice. In addition, DPPI-KO mice showed a decrease in overall inflammatory status mediated by diabetes induction which was manifested by decreased production of pro-inflammatory cytokines like TNF-α, IL-1β and IL-6.

conclusionThis study elucidates a novel role of ISPs in potentiating the immunological responses that lead to the pathogenesis of DCM in T1DM. To the best of our knowledge, this is the first study to report that DPPI expression and activation promotes the inflammation that enhances myocyte apoptosis and contributes to the adverse cardiac remodeling that subsequently leads to DCM.

Indexed as

AnimalsApoptosisbcl-2-Associated X ProteinBlood GlucoseCathepsin CDiabetes Mellitus, ExperimentalDiabetic CardiomyopathiesDown-RegulationFibrosisHeartHeart VentriclesInterleukin-1betaMaleMiceMice, Inbred C57BLMice, Knockoutbcl-2-Associated X ProteinBlood GlucoseCathepsin CInterleukin-1betaProto-Oncogene Proteins c-bcl-2Serine ProteasesTumor Necrosis Factor-alphaApoptosis; Diabetic cardiomyopathy (DCM); Dipeptidyl peptidase I (DPPI); ER stress; Inflammatory serine protease (ISP)

Identifiers

PMID31829530
PMCPMC6956403
OpenAlexW2998274131

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.